Rationale for and Design of the CREATIVE-AF Trial: Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effect of Irbesartan on Oxidative Stress and Adhesion Molecules in Patients with Persistent Atrial Fibrillation

Author: Goette Andreas  

Publisher: Adis International

ISSN: 1173-2563

Source: Clinical Drug Investigation, Vol.28, Iss.9, 2008-01, pp. : 565-572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content